Market Research Logo

Global Basal cell Carcinoma Therapeutics Market 2018-2022

Global Basal cell Carcinoma Therapeutics Market 2018-2022

About this market

The advancements in the field of oncology research is expected to help the market grow during the forecast period. The key players in the market are constantly developing medicines for various cancer indications. Technavio’s analysts have predicted that the basal cell carcinoma therapeutics market will register a CAGR of around 6% by 2022.

Market Overview

Heavy investments to develop a strong R&D department

The market is expected to be driven by the heavy investments incurred to develop a strong R&D department for basal cell carcinoma treatment. Cancer is considered one of the most common causes of death across the globe, and the prevalence of cancer has witnessed a rapid surge in the past few years.

Higher demand for the surgical treatments for basal cell carcinoma

One of the major challenges faced by the global basal cell carcinoma therapeutics market is the availability of non-therapeutic treatment options such as surgeries.

For the detailed list of factors that will drive and challenge the growth of the basal cell carcinoma therapeutics market during the 2019-2023, view our report.

Competitive Landscape

The market appears to be concentrated and with the presence of few vendors including Bausch Health and Biofrontera the competitive environment is quite intense. Factors such as the advancements in the field of oncology research and heavy investments to develop a strong R&D department, will provide considerable growth opportunities to basal cell carcinoma therapeutics manufactures. Bausch Health, Biofrontera, Mylan, Sun Pharmaceutical, and F. Hoffmann-La Roche are some of the major companies covered in this report.

‘With the presence of a considerable number of companies, this market appears to be fragmented. This market research report will help clients identify new growth opportunities. Some of the established pharmaceutical companies and various government organizations are investing profoundly in the R&D of novel therapies, which is currently dominated by biologic molecules due to their high effectiveness.’


PRESS RELEASE

Technavio Announces the Publication of its Research Report – Global Basal Cell Carcinoma Therapeutics Market 2019-2023

Technavio recognizes the following companies as the key players in the global basal cell carcinoma therapeutics market: Bausch Health, Biofrontera, Mylan, Sun Pharmaceutical, and F. Hoffmann-La Roche.

Commenting on the report, an analyst from Technavio’s team said: “The latest trend gaining momentum in the market is the advancements in the field of oncology research.”

According to the report, one of the major drivers for this market is the Heavy investments to develop a strong R&D department.

Further, the report states that one of the major factors hindering the growth of this market is the higher demand for the surgical treatments for basal cell carcinoma.

Companies Mentioned

Bausch Health

Biofrontera

F. Hoffmann-La Roche

Mylan

Sun Pharmaceutical

  • Executive summary
  • Scope of the report
  • Research methodology
  • Disease overview
    • Basal cell carcinoma
  • Market landscape
    • Market ecosystem
      • Table Parent market
      • Table Global oncology drugs market
    • Market characteristics
      • Table Market characteristics
    • Market segmentation analysis
      • Table Market segments
  • Market sizing
    • Market definition
      • Table Market definition - Inclusions and exclusions checklist
    • Market sizing 2017
      • Table Market size 2017
      • Table Validation techniques employed for market sizing 2017
    • Market size and forecast 2017-2022
      • Table Global basal cell carcinoma therapeutics market – Market size and forecast 2017-2022 ($ mn)
      • Table Global basal cell carcinoma therapeutics market – Year-over-year (YoY) growth 2018- 2022 (%)
  • Five forces analysis
    • Table Five forces analysis 2018
    • Table Five forces analysis 2022
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition - Five forces 2017
  • Pipeline
    • Table Pipeline landscape by development phase
    • Table Global basal cell carcinoma pipeline: Overview
  • Market segmentation by RoA
    • Segmentation by RoA
      • Table Global basal cell carcinoma therapeutics market by RoA – Market share 2017-2022 (%)
    • Comparison by RoA
      • Table Global basal cell carcinoma therapeutics market - Comparison by RoA
    • Topical RoA – Market size and forecast 2017-2022
      • Table Global basal cell carcinoma therapeutics market by topical RoA – Market size and forecast 2017-2022 ($ mn)
      • Table Global basal cell carcinoma therapeutics market by topical RoA – YoY growth 2018-2022 (%)
    • Oral RoA – Market size and forecast 2017-2022
      • Table Global basal cell carcinoma therapeutics market by oral RoA – Market size and forecast 2017-2022 ($ mn)
      • Table Global basal cell carcinoma therapeutics market by oral RoA – YoY growth 2018-2022 (%)
    • Market opportunity by RoA
      • Table Market opportunity by RoA
  • Customer landscape
    • Table Customer landscape
  • Regional landscape
    • Geographical segmentation
      • Table Global basal cell carcinoma therapeutics market – Market share by geography 2017- 2022 (%)
    • Regional comparison
      • Table Global basal cell carcinoma therapeutics market: Regional comparison
    • Americas – Market size and forecast 2017-2022
      • Table Basal cell carcinoma therapeutics market in Americas – Market size and forecast 2017- 2022 ($ mn)
      • Table Basal cell carcinoma therapeutics market in Americas – YoY growth 2018-2022 (%)
    • EMEA – Market size and forecast 2017-2022
      • Table Basal cell carcinoma therapeutics market in EMEA – Market size and forecast 2017-2022 ($ mn)
      • Table Basal cell carcinoma therapeutics market in EMEA – YoY growth 2018-2022 (%)
    • APAC – Market size and forecast 2017-2022
      • Table Basal cell carcinoma therapeutics market in APAC – Market size and forecast 2017-2022 ($ mn)
      • Table Basal cell carcinoma therapeutics market in APAC – YoY growth 2018-2022 (%)
    • Key leading countries
      • Table Key leading countries: Overview
    • Market opportunity
      • Table Global basal cell carcinoma therapeutics market - Market opportunity
  • Decision framework
  • Drivers and challenges
    • Market drivers
    • Market challenges
  • Market trends
    • Advancements in the field of oncology research
  • Vendor landscape
    • Overview
      • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
  • Vendor analysis
    • Vendors covered
      • Table Vendors covered - Overview
    • Vendor classification
      • Table Vendor classification
    • Market positioning of vendors
      • Table Market positioning of vendors
    • Bausch Health
      • Table Bausch Health: Overview
      • Table Bausch Health – Business segments
      • Table Bausch Health – Organizational developments
      • Table Bausch Health – Geographic focus
      • Table Bausch Health – Segment focus
      • Table Bausch Health – Key offerings
      • Table Bausch Health – Key customers
    • Biofrontera
      • Table Biofrontera: Overview
      • Table Biofrontera – Organizational developments
      • Table Biofrontera – Geographic focus
      • Table Biofrontera – Key offerings
      • Table Biofrontera – Key customers
    • F. Hoffmann-La Roche
      • Table F. Hoffmann-La Roche: Overview
      • Table F. Hoffmann-La Roche – Business segments
      • Table F. Hoffmann-La Roche – Organizational developments
      • Table F. Hoffmann-La Roche – Geographic focus
      • Table F. Hoffmann-La Roche – Segment focus
      • Table F. Hoffmann-La Roche – Key offerings
      • Table F. Hoffmann-La Roche – Key customers
    • Mylan
      • Table Mylan: Overview
      • Table Mylan – Business segments
      • Table Mylan – Organizational developments
      • Table Mylan – Geographic focus
      • Table Mylan – Segment focus
      • Table Mylan – Key offerings
      • Table Mylan – Key customers
    • Sun Pharmaceutical
      • Table Sun Pharmaceutical: Overview
      • Table Sun Pharmaceutical – Business segments
      • Table Sun Pharmaceutical – Organizational developments
      • Table Sun Pharmaceutical – Geographic focus
      • Table Sun Pharmaceutical – Key offerings
      • Table Sun Pharmaceutical – Key customers
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report